Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker - Summary - MDSpire

Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker

  • By

  • Huan Zhao

  • Chunlei Zheng

  • Yizhe Wang

  • Kezuo Hou

  • Xianghong Yang

  • Yang Cheng

  • Xiaofang Che

  • Shilin Xie

  • Shuo Wang

  • Tieqiong Zhang

  • Jian Kang

  • Yunpeng Liu

  • Dianzhu Pan

  • Xiujuan Qu

  • Xuejun Hu

  • Yibo Fan

  • July 3, 2026

  • 0 min

Share

Objective:

To correct references and figures in the original article regarding miR-1323's role in lung adenocarcinoma.

Approach:
  • Reference Corrections: Replaced retracted references with new citations related to microRNA studies in lung cancer.
  • Figure Corrections: Corrected errors in Figures 4B and 6D where images were repeated.
Key Findings:
  • Reference for Xu et al. (2018) was retracted and replaced with Wang et al. (2018).
  • Reference for Qian et al. (2018) was retracted and replaced with Chen and Ruan (2019).
  • Reference for Jiang et al. (2016) was retracted and replaced with Peng and Croce (2016).
  • Figures 4B and 6D contained repeated images and have been corrected.
Interpretation:

The corrections ensure the accuracy of the references and figures in the study.

Conclusion:

The original article has been updated to reflect these corrections.

Original Source(s)

Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker

  • by Huan Zhao, Chunlei Zheng, Yizhe Wang, Kezuo Hou, Xianghong Yang, Yang Cheng, Xiaofang Che, Shilin Xie, Shuo Wang, Tieqiong Zhang, Jian Kang, Yunpeng Liu, Dianzhu Pan, Xiujuan Qu, Xuejun Hu, Yibo Fan

  • July 3, 2026

Related Content

Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis

Dynamic consent framework for low-dose CT scan lung cancer screening: autonomy, privacy, ethical data management

Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis